z-logo
open-access-imgOpen Access
Growth Hormone Response during Oral Glucose Tolerance Test: The Impact of Assay Method on the Estimation of Reference Values in Patients with Acromegaly and in Healthy Controls, and the Role of Gender, Age, and Body Mass Index
Author(s) -
Ayman M. Arafat,
Matthias Möhlig,
Martin O. Weickert,
F. H. Perschel,
J Purschwitz,
Joachim Spranger,
Christian J. Strasburger,
Christof Schöfl,
A. Pfeiffer
Publication year - 2008
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2007-2084
Subject(s) - acromegaly , medicine , liter , body mass index , endocrinology , growth hormone , basal (medicine) , confounding , confidence interval , pituitary disease , gastroenterology , hormone , insulin
Besides the measurement of IGF-I, GH suppression during an oral glucose tolerance test is recommended to assess the biochemical status in acromegaly. However, the development of highly sensitive and specific GH assays necessitates a critical reevaluation of criteria for diagnosis and follow-up of disease activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom